Fortis Healthcare’s Board has approved the unaudited standalone and consolidated financial results for the quarter and six months ended September 30, 2025. Standalone revenue from operations stood at ₹45,581 lacs for the quarter. Consolidated revenue from operations was ₹233,144 lacs for the same period. The board has co-operated with relevant regulatory authorities and has also initiated necessary actions for legal rights, as needed.
Financial Performance
For the quarter ended September 30, 2025, Fortis Healthcare reported the following standalone results:
- Revenue from operations: ₹45,581 lacs
- Other income: ₹9,242 lacs
- Total income: ₹54,823 lacs
- Net profit: ₹12,509 lacs
The consolidated results for the quarter ending September 30, 2025 are:
- Revenue from operations: ₹233,144 lacs
- Other income: ₹2,258 lacs
- Total income: ₹235,402 lacs
- Net profit: ₹32,882 lacs
Segment Reporting
The segment results for the quarter ending September 30, 2025 are broken down as follows:
- Healthcare: Revenue: ₹197,382 lacs, Profit: ₹37,566 lacs
- Diagnostics: Revenue: ₹39,963 lacs, Profit: ₹7,483 lacs
Regulatory & Legal Matters
The board has addressed concerns from investigations by the Serious Fraud Investigation Office (SFIO) and is fully cooperating. They have undertaken reviews regarding historical transactions. Additionally, all required findings have been submitted to regulatory authorities, and legal proceedings have been initiated where action is recommended by legal counsel. The group believes it maintains a strong case on merits and further impact on financial results isn’t expected to be material.
Other Key Highlights
- On October 16, 2025, it completed the Fortis and Malar Open Offers.
- Pursuant to an order dated September 16, 2025, it deposited ₹55.37 Crores towards the license fee for the ‘Fortis’ trademark.
- During the quarter, Fortis entered into an operations and maintenance service agreement with Gleneagles Healthcare India Private Limited for five hospitals and one clinic which is effective from July 23, 2025.
Source: BSE
